Strategy

Versant Ventures eyes start-ups in Europe

Read more

JP Morgan forum ends on a positive note

Read more

Market Commentary: How risky are European biotechs?

Read more

Cheap capital gives rise to integrated pharma R&D

Read more

Commentary: Thought disruption in R&D discovery

Read more

Market Analysis: The outlook for European pharma

Read more

New risk capital for European companies

Read more

A strategy for treating traumatic brain injury

Read more

Debate heats up over germline editing

Read more

Bioelectronics creates new horizon for medicine

Read more